Picture of Med Life SA logo

M Med Life SA Share Price

0.000.00%
ro flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Momentum

Relative Strength (%)
1m-5.51%
3m-13.8%
6m-24.7%
1yr-25.13%
Volume Change (%)
10d/3m-26.28%
Price vs... (%)
52w High-19.78%
50d MA-1.78%
200d MA-10.44%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)32.96
PEG Ratio (f)0.34
EPS Growth (f)2,300%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.97
Price to Tang. Bookn/a
Price to Free Cashflow52.39
Price to Sales1
EV to EBITDA13.18

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.14%
Return on Equity-2.97%
Operating Margin3.6%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueRONm794.56967.381,077.451,427.221,795.432,178.42,486.723.57%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+740.3-5.52+286.91+91.71-70.16-91.38+2300n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Med Life SA EPS forecast chart

Profile Summary

Med Life SA is a Romania-based company engaged in the healthcare industry. Its portfolio of medical services includes clinical and laboratory testing services, medical imaging, reproductive medicine, hospital admission and surgical interventions, among others. Med Life SA offers treatments in the areas of dental, orthopedics and traumatology, gynecology, plastic and reconstructive surgery, oncology and surgical oncology, infertility and assisted reproduction, medical genetics, and medical checkups, spinal, pediatric and genitourinary surgeries, among others. The Company operates over 10 clinics, around five hospitals, an ambulatory facilities, over 15 test laboratories and around five maternity hospitals, among others.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
May 6th, 1996
Public Since
December 21st, 2016
No. of Employees
6,281
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
ro flag iconBucharest Stock Exchange
Shares in Issue
531,481,968

M Share Price Performance

Upcoming Events for M

Full Year 2023 Med Life SA Earnings Call

Full Year 2023 Med Life SA Earnings Release

Q1 2024 Med Life SA Earnings Call

Q1 2024 Med Life SA Earnings Release

FAQ